Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118058512 | 11805851 | 2 | F | 2015 | 20160429 | 20151207 | 20160810 | PER | US-ASTRAZENECA-2015SF19344 | ASTRAZENECA | 70.00 | YR | M | Y | 70.30000 | KG | 20160810 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118058512 | 11805851 | 1 | PS | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | TWO 40 MG CAPSULES, EQUALING 80MG, TWICE A DAY, TOTALING 160 | 21153 | CAPSULE | |||||||||
118058512 | 11805851 | 2 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 20.0MG UNKNOWN | N | U | 0 | 20 | MG | CAPSULE | |||||
118058512 | 11805851 | 3 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 80.0MG UNKNOWN | N | U | 0 | 80 | MG | CAPSULE | BID | ||||
118058512 | 11805851 | 4 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 40MG IN THE MORNING AND 20MG IN THE EVENING UNKNOWN | N | U | 0 | ||||||||
118058512 | 11805851 | 5 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 2 40 MG CAPSULES, EQUALING 80MG, TWICE A DAY, TOTALING 160 MG UNKNOWN | N | U | 0 | CAPSULE | |||||||
118058512 | 11805851 | 6 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Oral | 40.0MG UNKNOWN | N | U | 0 | 40 | MG | BID | |||||
118058512 | 11805851 | 7 | SS | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | Unknown | GENERIC UNKNOWN | N | U | 0 | ||||||||
118058512 | 11805851 | 8 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
118058512 | 11805851 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
118058512 | 11805851 | 10 | C | BYSTOLIC | NEBIVOLOL HYDROCHLORIDE | 1 | Oral | 2.5MG AS REQUIRED | 0 | 2.5 | MG | ||||||||
118058512 | 11805851 | 11 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | Oral | 2.5MG AS REQUIRED | 0 | 2.5 | MG | ||||||||
118058512 | 11805851 | 12 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 2.5MG AS REQUIRED | 0 | 2.5 | MG | ||||||||
118058512 | 11805851 | 13 | C | CALCIUM SUPPLEMENT | CALCIUM | 1 | Oral | 2.5MG AS REQUIRED | 0 | 2.5 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
118058512 | 11805851 | 1 | Gastrooesophageal reflux disease |
118058512 | 11805851 | 2 | Gastrooesophageal reflux disease |
118058512 | 11805851 | 3 | Gastrooesophageal reflux disease |
118058512 | 11805851 | 4 | Gastrooesophageal reflux disease |
118058512 | 11805851 | 5 | Gastrooesophageal reflux disease |
118058512 | 11805851 | 6 | Gastrooesophageal reflux disease |
118058512 | 11805851 | 7 | Gastrooesophageal reflux disease |
118058512 | 11805851 | 9 | Stent placement |
118058512 | 11805851 | 10 | Arrhythmia |
118058512 | 11805851 | 12 | Blood cholesterol abnormal |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118058512 | 11805851 | Depression | |
118058512 | 11805851 | Discomfort | |
118058512 | 11805851 | Drug ineffective | |
118058512 | 11805851 | Gastritis | |
118058512 | 11805851 | Gastrointestinal motility disorder | |
118058512 | 11805851 | Hiatus hernia | |
118058512 | 11805851 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
118058512 | 11805851 | 1 | 201510 | 0 | ||
118058512 | 11805851 | 2 | 1991 | 0 | ||
118058512 | 11805851 | 3 | 1991 | 201510 | 0 | |
118058512 | 11805851 | 4 | 1995 | 201510 | 0 | |
118058512 | 11805851 | 6 | 2015 | 0 | ||
118058512 | 11805851 | 7 | 2015 | 0 | ||
118058512 | 11805851 | 9 | 2001 | 0 | ||
118058512 | 11805851 | 10 | 1995 | 0 | ||
118058512 | 11805851 | 11 | 1995 | 0 | ||
118058512 | 11805851 | 12 | 1995 | 0 | ||
118058512 | 11805851 | 13 | 1995 | 0 |